OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Jiangsu Hengrui Pharmaceuticals Co OCF Yield % Explanation
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Jiangsu Hengrui Pharmaceuticals Co OCF Yield % Related Terms
Jiangsu Hengrui Pharmaceuticals Co OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangsu Hengrui Pharmaceuticals Co OCF Yield % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Hengrui Pharmaceuticals Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jiangsu Hengrui Pharmaceuticals Co OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jiangsu Hengrui Pharmaceuticals Co's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Jiangsu Hengrui Pharmaceuticals Co's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) has a OCF Yield % of 3.11 as of Jul. 07, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Jiangsu Hengrui Pharmaceuticals Co and its competitors. This is 145% above median its historical median of 1.27. Over the past decade, Jiangsu Hengrui Pharmaceuticals Co's OCF Yield % has ranged from 0.37 to 3.63. According to the industry distribution chart, Jiangsu Hengrui Pharmaceuticals Co ranks #523 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 51.9%.
Is Jiangsu Hengrui Pharmaceuticals Co's OCF Yield % too high?
Jiangsu Hengrui Pharmaceuticals Co's current OCF Yield % of 3.11 is 145% above median its 10-year median of 1.27. Over the past 10 years, this metric has ranged from a low of 0.37 to a high of 3.63. The Drug Manufacturers industry median OCF Yield % is 3.51. Jiangsu Hengrui Pharmaceuticals Co's value of 3.11 is 11.4% below this industry median. Based on the distribution chart, Jiangsu Hengrui Pharmaceuticals Co ranks #523 out of 1007 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Jiangsu Hengrui Pharmaceuticals Co has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Hengrui Pharmaceuticals Co's OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jiangsu Hengrui Pharmaceuticals Co ranks #523 out of 1007 companies for OCF Yield %. This places Jiangsu Hengrui Pharmaceuticals Co in the lower half of its industry. The industry median OCF Yield % is 3.51. Jiangsu Hengrui Pharmaceuticals Co's value of 3.11 is 11.4% below this benchmark. Historically, Jiangsu Hengrui Pharmaceuticals Co's own OCF Yield % has ranged from 0.37 to 3.63 over the past decade. While the company's 10-year median is 1.27 vs. the industry median of 3.51, Jiangsu Hengrui Pharmaceuticals Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.51, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jiangsu Hengrui Pharmaceuticals Co's current OCF Yield % of 3.11 is 11.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Jiangsu Hengrui Pharmaceuticals Co and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jiangsu Hengrui Pharmaceuticals Co's current OCF Yield % is 3.11, which is 145% above median its own 10-year median of 1.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Hengrui Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) is currently considered Fairly Valued. The stock's GF Value™ is ¥60.61, compared to a current price of ¥55.65 — trading 8.2% below its estimated fair value. The current OCF Yield % is 3.11, which is 145% above median its 10-year median of 1.27 and 11.4% below the Drug Manufacturers industry median of 3.51. Jiangsu Hengrui Pharmaceuticals Co's overall GF Score™ is 86/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276), the current OCF Yield % is 3.11 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Overvalued in 2026?
Based on GuruFocus' analysis, Jiangsu Hengrui Pharmaceuticals Co stock appears to be undervalued.
The current stock price of ¥55.65 is trading 8.2% below its estimated GF Value™ of ¥60.61.
GuruFocus considers Jiangsu Hengrui Pharmaceuticals Co to be Fairly Valued.
Key valuation signals for SHSE:600276:
OCF Yield %: 3.11 (145% above median its 10-year median of 1.27)
GF Value™: ¥60.61 vs. price of ¥55.65 (8.2% below fair value)
Industry Position: 11.4% below the Drug Manufacturers median (#523 of 1007)
No single metric tells the full story. See the SHSE:600276 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jiangsu Hengrui Pharmaceuticals Co Business Description
Jiangsu Hengrui Pharmaceuticals Co Ltd is a biopharmaceutical company that engages in the research, development, manufacture, and sale of drugs. It is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs, and anti-infection medications. The company specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system. Geographically, the company is segmented as Chinese mainland and Other countries generating majority revenue from the Chinese region.
86GF Score
Get the complete analysis for SHSE:600276
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600276 has been successfully added to your 
